Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.
COVID-19 was associated with more severe disease outcomes than influenza or RSV during the 2022 to 2023 season.
RSV is a common virus that affects the lungs and breathing passages, and here are some steps you can take to protect yourself ...
GB News on MSN3h
New jab offered to millions of pensioners and pregnant women 'could cause neurological illness' as health chiefs issue vaccine safety alertUS health officials have issued a warning linking RSV vaccines to an increased risk of a serious neurological condition. The ...
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
Pregnant women in the Northern Territory (NT) can now receive the respiratory syncytial virus (RSV) vaccine for free under the National Immunisation ...
Levels of respiratory illnesses such as COVID-19, influenza and RSV are on the rise. Here’s what you can do to keep yourself ...
21h
From today, February 3, pregnant women in Australia will be eligible for a free RSV vaccine under the National Immunisation ...
1d
Once home, I was convinced I’d never sleep again for fear of more episodes of apnea. We purchased a specialized baby monitor ...
The UKHSA has noted that COVID symptoms have evolved over time. Many individuals now exhibit cold-like symptoms, but others ...
As health officials report a surge of winter viruses, health experts are warning that heart disease symptoms can sometimes ...
The UK Health Security Agency (UKHSA) has issued a new warning this morning after a range of winter bugs started spreading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback